Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.
John R De AlmeidaChristopher W NoelDavid FornerHan ZhangAnthony C NicholsMarc A CohenRichard J WongCaitlin McMullenEvan M GraboyesVasu DiviAndrew G ShumanAndrew J RoskoCarol M LewisEhab Y HannaJeffrey MyersVinidh PaleriBrett MilesEric GendenAntoine EskanderDanny J EnepekidesKevin M HigginsDale BrownDouglas B ChepehaIan J WitterickPatrick J GullaneJonathan C IrishEric MonteiroDavid P GoldsteinRalph GilbertPublished in: Cancer (2020)
Many countries have enacted strict rules regarding the use of hospital resources during the coronavirus disease 2019 (COVID-19) pandemic. Facing delays in surgery, patients may experience worse functional outcomes, stage migration, and eventual inoperability. Treatment prioritization tools have shown benefit in helping to triage patients equitably with minimal provider cognitive burden. The current study sought to develop what to the authors' knowledge is the first cancer-specific surgical prioritization tool for use in the COVID-19 era, the Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN). This algorithm consistently stratifies patients requiring head and neck cancer surgery in the COVID-19 era and provides evidence for the initial uptake of the SPARTAN-HN.
Keyphrases
- coronavirus disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- sars cov
- emergency department
- healthcare
- prognostic factors
- primary care
- machine learning
- squamous cell carcinoma
- peritoneal dialysis
- patient reported outcomes
- acute coronary syndrome
- respiratory syndrome coronavirus
- neural network
- squamous cell